Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma

NCT01634958 is registered in ClinicalTrials.gov with Leti Pharma GmbH as lead sponsor.

NCT NCT01634958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01634958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma
Lead sponsor
Leti Pharma GmbH
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2013
Enrollment
308 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis/rhinoconjunctivitis +- intermittent asthma, dose-finding study, sensitization against phleum pratense pollen